Aug. 12, 2024 — Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Summary: Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this aggressive brain cancer. By analyzing stem cells derived from ...

Nov. 26, 2024 — Scientists have shed new light on how certain biological processes determine the development of neural cells. Their findings on a molecular 'bridge' complex demonstrate a new ...

These targets were identified through a screen for genetic vulnerabilities in patient-derived cancer stem cells that represent the variability found in tumors. Glioblastoma is the most common type ...

It is also the most challenging to treat due to the resistance of glioblastoma cancer stem cells, from which tumors grow, to therapy. Cancer stem cells that survive after a tumor is treated go on ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer. The targets were identified ...